RetinalGenix Technologies (RTGN) Share-based Compensation (2020 - 2026)
RetinalGenix Technologies' (RTGN) quarterly Share-based Compensation came in at $210016.0 in Q1 2026, down 9.45% year-on-year from $231933.0 in Q1 2025, and down 25.33% quarter-over-quarter from $281246.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Share-based Compensation (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has disclosed Share-based Compensation across 7 years of filings, most recently posting $210016.0 for Q1 2026.
- Share-based Compensation for Q1 2026 came in at $210016.0, down 9.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (down 8.14% YoY), and the FY2025 annual result was $1.0 million, down 60.13% from the prior year.
- Share-based Compensation came in at $210016.0 for Q1 2026 at RetinalGenix Technologies, down from $281246.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.7 million in Q1 2024 to a low of $55051.0 in Q1 2022.
- The 5-year median for Share-based Compensation is $211009.0 (2024), against an average of $281406.1.
- Across the five-year window, Share-based Compensation soared 2107.18% in 2024 and plunged 86.62% in 2025, its largest moves.
- RetinalGenix Technologies' Share-based Compensation stood at $78509.0 in 2022, then fell by 0.0% to $78507.0 in 2023, then surged by 370.9% to $369687.0 in 2024, then decreased by 23.92% to $281246.0 in 2025, then retreated by 25.33% to $210016.0 in 2026.
- The last three Share-based Compensation figures came in at $210016.0 (Q1 2026), $281246.0 (Q4 2025), and $277226.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 45.40 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 35.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 43.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 12.90 Mn |
| 10 | RetinalGenix Technologies | - | - | - | 210,016.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,016.00 |
| Mar 31, 2026 | 210,016.00 |
| Dec 31, 2025 | 281,246.00 |
| Dec 31, 2025 | 281,246.00 |
| Sep 30, 2025 | 277,226.00 |
| Sep 30, 2025 | 277,226.00 |
| Jun 30, 2025 | 250,189.00 |
| Jun 30, 2025 | 250,189.00 |
| Mar 31, 2025 | 231,933.00 |
| Mar 31, 2025 | 231,933.00 |
| Dec 31, 2024 | 369,687.00 |
| Dec 31, 2024 | 369,687.00 |
| Sep 30, 2024 | 296,256.00 |
| Sep 30, 2024 | 296,256.00 |
| Jun 30, 2024 | 211,009.00 |
| Jun 30, 2024 | 211,009.00 |
| Mar 31, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 78,507.00 |
| Dec 31, 2023 | 78,507.00 |